NCT02282709View on ClinicalTrials.gov

Effect of ASV and DCV Therapy on the Quality of Immune Status in Chronic HCV Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Chronic Hepatitis C
Interventions
DRUG

Daclatasvir

60 mg once daily

DRUG

asunaprevir

100 mg BID

Trial Locations (1)

3015 CE

Erasmus Medical Center, Rotterdam

Sponsors
All Listed Sponsors
lead

Foundation for Liver Research

OTHER